Recursion Provides Business Updates and Reports Third Quarte

/PRNewswire/ -- Recursion (Nasdaq: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today reported business...

Related Keywords

Montreal , Quebec , Canada , Salt Lake City , Utah , United States , Toronto , Ontario , , Development Expenses , Genentech , Recursion Pharmaceuticals Inc , Institutional Shareholder Services , Chemical Technology , Cavernous Malformation , Adenomatous Polyposis , Industrialized Validation , Digital Tolerability , Machine Learning , Placement Offering , Prime Rating , Administrative Expenses , San Francisco Bay , Consolidated Statements , Consolidated Balance Sheets , Recursion ,